Sign up to save your podcasts
Or
Share Ocular Therapeutics Sustained Release TKI Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ocular Therapeutics Sustained Release TKI Trial
We review the current status of the Ocular Therapeutics TKI sustained release delivery system for treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology USC Roski Eye Institute.
View all episodes
By Retina Synthesis
4.5
88 ratings
We review the current status of the Ocular Therapeutics TKI sustained release delivery system for treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology USC Roski Eye Institute.
More shows like Retina Synthesis
View all
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners